Report Includes

• Detailed overview of global market for Active Pharmaceutical Ingredients (APIs) within the pharmaceutical industry
• Country specific data and analysis for United States, Canada, Mexico, France, Germany, U.K., Italy, Spain, China, India, Japan, Brazil, South Africa, and UAE
• Segmentation of the global market by molecular entity, manufacturer type, end use, and geographical region
• Identification of factors such as challenges, trends and emerging opportunities that impact the future market dynamics
• A look at the current regulatory updates, new developments, mergers and acquisitions and partnership activities, and patent expiry shaping the API market landscape
• Examination of vendor landscape and detailed profiles of the major vendors in the global API market

This report provides:

• An overview of the global market for cognition and memory enhancement drugs.
• Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022.
• An overview of the ethics and side effects of cognition and memory enhancement drugs.
• Market analyses by application, product, and region.
• Assessment of patent litigation claims.
• Insight into the competitive landscape, including mergers and acquisitions and new product launches.
• Profiles of key companies in the market.

This report provides: 

• An overview of the global market for neuroprotective agents and their therapeutic applications.
• Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022.
• Market breakdowns by indication, mechanism of action, and by region.
• Introduction of breakthrough biomarker studies that assist in neuroprotection.
• Discussion of various neurodegenarative disorders.
• Profiles of key companies in the market.

This report provides:

• An overview of the global in vitro toxicity testing market, with assessments of its growth potential over the next five years and the current market scenario for alternative measures to animal testing.
• Analyses of global market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021.
• Discussion of the two major technology-based approaches, mechanistic and nonmechanistic.
• A breakdown of influential factors, such as validation of the alternative measures for toxicity and toxicity testing strategies for chemicals, pesticides, and food additives.
• Evaluations covering equipment, assays, cells, reagents, and services used in toxicity testing.
• Company profiles of major players in the market.

This report provides: 

• An overview of the global market for contract research organization (CRO) services.
• Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022.
• Analyses of the CRO market by services, trial phases, and by region.
• Descriptions of FDA regulations.
• Insight into the competitive landscape of the market, including mergers and acquisitions, and current pharma-CRO contracts.
• Profiles of key companies in the market.

This report provides:

• An overview of the global markets for advanced wound care and related technologies.
• Analyses of global market trends, with data from 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2023.
• Information on various products and segments in the market, such as biological dressings, surgical sealants, synthetic dressings, anti-adhesion products and other wound healing products and devices.
• Analyses of key strategies, competitive insights, and developments of key companies in the market.
• Evaluation of challenges in the market, including the higher price associated with advanced therapies over traditional methods, which have been augmented by decreasing hospital and surgery center budgets due to economic downturns felt in many developed nations.
• A look at how new technological products are competing in a fast-track market that seeks to improve the quality of life for millions of individuals needing both acute and chronic wound care.
• Comprehensive company profiles. 

This report provides: 

• An overview of the global market for checkpoint (CP) inhibitors.
• Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022.
• Discussion of the market landscape and innovative strategies, and the areas of unmet medical needs.
• Information on the biomarker development, immune modulation, innovative delivery technologies, and the future landscape.
• Market analysis for CP inhibitors, including PD-1/PD-L1 agents, CTLA-4 agents, Tim-3 agents, LAG-3 agents, IDO-1 agents, and SIRPα agents.
• Comprehensive company profiles.

This report provides:

• An overview of the global research and development investments in over-the-counter (OTC) drugs and nutraceuticals.
• Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022.
• Discussion of the strategies and plans behind research-and-development activities.
• Estimation of investments in R&D activities in OTC drugs by therapeutic classification, routes of OTC drug administration, companies, institutions, and regions.
• Macro- and micro-level scenarios, insights, and analyses of global R&D initiatives around OTC drugs.
• Company profiles of key players in the industry based on their market shares, product offerings, and regions.

This report provides:

• An overview of the global markets for pharmaceuticals, specifically healthcare legislation and regulation, pricing mechanisms, and reimbursement procedures.
• Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022.
• Information on the current price and reimbursement landscape, benchmarking statics, and future development opportunities in the pharma industry.
• Case studies of different price and reimbursement strategies for prescription drugs, generics, biosimilars, hospitals, and over-the-counter products.
• Coverage of market dynamics, specifically growth drivers, restraints, and opportunities.
• Comprehensive company profiles of major players in the industry.